Edgewood Management LLC Gilead Sciences, Inc. Transaction History

Edgewood Management LLC

$37.1 Billion
Q3 2024

A detailed history of Edgewood Management LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Edgewood Management LLC holds 39,930 shares of GILD stock, worth $3.71 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

39,930

Previous 41,015 2.65%

Holding current value

$3.71 Million

Previous $2.81 Million 18.91%

% of portfolio

0.01%

Previous 0.01%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$66.59 - $83.99 $72,250 - $91,129	-1,085 Reduced 2.65%	39,930 $3.35 Million
Q2 2024 Aug 13, 2024	SELL	$63.15 - $72.88 $168,357 - $194,298	-2,666 Reduced 6.1%	41,015 $2.81 Million
Q1 2024 May 14, 2024	SELL	$71.58 - $87.29 $136,002 - $165,851	-1,900 Reduced 4.17%	43,681 $3.2 Million
Q1 2023 May 12, 2023	SELL	$77.31 - $88.08 $3.02 Million - $3.44 Million	-39,000 Reduced 46.11%	45,581 $3.78 Million
Q4 2022 Feb 13, 2023	SELL	$62.32 - $89.47 $80,642 - $115,774	-1,294 Reduced 1.51%	84,581 $7.26 Million
Q2 2022 Aug 12, 2022	SELL	$57.72 - $65.01 $9,985 - $11,246	-173 Reduced 0.2%	85,875 $5.31 Million
Q4 2021 Feb 11, 2022	SELL	$64.88 - $73.64 $289,299 - $328,360	-4,459 Reduced 4.93%	86,048 $6.25 Million
Q3 2021 Nov 12, 2021	SELL	$67.69 - $73.03 $34,860 - $37,610	-515 Reduced 0.57%	90,507 $6.32 Million
Q1 2021 May 13, 2021	SELL	$60.0 - $68.46 $59,160 - $67,501	-986 Reduced 1.07%	91,022 $5.88 Million
Q4 2020 Feb 12, 2021	SELL	$56.65 - $64.55 $56,650 - $64,550	-1,000 Reduced 1.08%	92,008 $5.36 Million
Q3 2020 Nov 12, 2020	SELL	$62.1 - $78.08 $886,415 - $1.11 Million	-14,274 Reduced 13.31%	93,008 $5.88 Million
Q2 2020 Aug 12, 2020	SELL	$72.34 - $84.0 $17,289 - $20,076	-239 Reduced 0.22%	107,282 $8.25 Million
Q1 2020 May 13, 2020	BUY	$62.63 - $80.22 $27,995 - $35,858	447 Added 0.42%	107,521 $8.04 Million
Q4 2019 Feb 14, 2020	BUY	$61.62 - $67.78 $846,165 - $930,754	13,732 Added 14.71%	107,074 $6.96 Million
Q3 2019 Nov 12, 2019	SELL	$62.51 - $69.0 $77,699 - $85,767	-1,243 Reduced 1.31%	93,342 $5.92 Million
Q2 2019 Aug 12, 2019	SELL	$61.87 - $69.38 $2.47 Million - $2.77 Million	-39,925 Reduced 29.68%	94,585 $6.39 Million
Q1 2019 May 13, 2019	SELL	$62.53 - $70.05 $3.05 Million - $3.42 Million	-48,843 Reduced 26.64%	134,510 $8.74 Million
Q4 2018 Feb 13, 2019	SELL	$60.54 - $79.0 $641,542 - $837,163	-10,597 Reduced 5.46%	183,353 $11.5 Million
Q3 2018 Nov 13, 2018	SELL	$71.28 - $78.92 $258,318 - $286,006	-3,624 Reduced 1.83%	193,950 $15 Million
Q2 2018 Aug 10, 2018	SELL	$64.88 - $75.68 $745,276 - $869,336	-11,487 Reduced 5.49%	197,574 $14 Million
Q1 2018 May 11, 2018	SELL	$72.84 - $88.8 $3,423 - $4,173	-47 Reduced 0.02%	209,061 $15.8 Million
Q4 2017 Feb 13, 2018	SELL	$71.15 - $83.52 $158,949 - $186,583	-2,234 Reduced 1.06%	209,108 $15 Million
Q3 2017 Nov 13, 2017	BUY	$72.11 - $85.47 $15.2 Million - $18.1 Million	211,342	211,342 $17.1 Million

Others Institutions Holding GILD

# of Institutions

1,926

Shares Held

993M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Edgewood Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Edgewood Management LLC with notifications on news.

Account

Edgewood Management LLC Gilead Sciences, Inc. Transaction History